Developing new drug therapies for brain tumors
Analytical Immunopharmacology
['FUNDING_OTHER'] · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · NIH-10928759
This study is looking at how to make treatments for brain tumors, especially glioblastoma, work better by understanding how drugs act in the brain, so that patients can have more effective options in the future.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | BECKMAN RESEARCH INSTITUTE/CITY OF HOPE (nih funded) |
| Locations | 1 site (DUARTE, UNITED STATES) |
| Trial ID | NIH-10928759 on ClinicalTrials.gov |
What this research studies
This research focuses on improving drug and biologic therapies for patients with central nervous system tumors, particularly glioblastoma. It utilizes advanced techniques in analytical chemistry and immunopharmacology to analyze how drugs behave in the brain and their effects on tumor cells. By collaborating with various research cores, the project aims to enhance the understanding of drug delivery and efficacy in the brain, ultimately supporting clinical trials that could lead to better treatment options for patients. The research employs sophisticated methods like intracerebral microdialysis to gather critical data on drug metabolism and response.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with glioblastoma or other central nervous system tumors who are seeking innovative treatment options.
Not a fit: Patients with non-cancerous brain conditions or those not diagnosed with central nervous system tumors may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for brain tumors, improving patient outcomes and survival rates.
How similar studies have performed: Previous research in similar areas has shown promise in improving drug therapies for brain tumors, indicating a potential for success in this approach.
Where this research is happening
DUARTE, UNITED STATES
- BECKMAN RESEARCH INSTITUTE/CITY OF HOPE — DUARTE, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: SYNOLD, TIMOTHY W — BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
- Study coordinator: SYNOLD, TIMOTHY W
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.